Temple University Hospital has reactivated its heart and lung transplant programs, effective immediately. "The reactivation of these transplant programs gives Temple the opportunity once again to bring a full range of sophisticated, lifesaving care to patients with end-stage lung and heart disease," said Larry R. Kaiser, Temple's senior executive vice president for health sciences, dean of the School of Medicine and president and CEO of Temple University Health System. PBJ had previously covered the hiring of renowned surgeon Yoshiya Toyoda in preparation for reactivating the program.